Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Eli Lilly and Company
Olema Pharmaceuticals, Inc.
NRG Oncology
Novartis
National Cancer Institute (NCI)
AstraZeneca
Hoffmann-La Roche
Eli Lilly and Company
Rovi Pharmaceuticals Laboratories
Canadian Cancer Trials Group
Stemline Therapeutics, Inc.
Shandong Suncadia Medicine Co., Ltd.
Centre Oscar Lambret
Olema Pharmaceuticals, Inc.
Pfizer
Sun Yat-sen University
University of Virginia
Hoffmann-La Roche
Alliance Foundation Trials, LLC.
SWOG Cancer Research Network
Pfizer
Eli Lilly and Company
Eli Lilly and Company
Shandong Suncadia Medicine Co., Ltd.
Fudan University
AstraZeneca
Tolmar Inc.
Tolmar Inc.
UNICANCER
Pfizer
UNICANCER
Stemline Therapeutics, Inc.
Sanofi
European Organisation for Research and Treatment of Cancer - EORTC
Xuanzhu Biopharmaceutical Co., Ltd.
AstraZeneca
National Cancer Institute (NCI)
University of California, San Francisco
SOLTI Breast Cancer Research Group
Alliance for Clinical Trials in Oncology
Region Örebro County
Novartis
Institut du Cancer de Montpellier - Val d'Aurelle
Pfizer
Novartis
UNICANCER
University of Ulm
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy